Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Herbalife Ltd. (HLF): Billionaire Carl Icahn’s Icahn Capital Raises Stake

Billionaire Icahn Carl‘s Icahn Capital has filed an amended Form 13D  with the US Securities and Exchange Commission, in which it reported raising its stake in Herbalife Ltd. (NYSE:HLF) to 21.44 million shares, which account for 23.05% of the float. As per the prior 13D filing on the company, the fund’s stake consisted of 19.3 million shares, which amassed 20.78% of the outstanding stock.

Herbalife is a world-renowned nutrition company that produces a variety of nutritional products. Since the beginning of the year, the company’s stock has gained 2.8%. For the third quarter of 2016, the company reported earnings per share of $1.21, topping the estimates of $1.09, and revenue of $1.12 billion, below the estimates of $1.14 billion. Recently, Pivotal Research reiterated its ‘Buy’ rating on the stock, with a price target of $90.

Most Popular Stocks Among Hedge Funds

Out of the 749 hedge funds that we track which filed 13Fs for the end of June, 35 reported long positions in Herbalife (NYSE:HLF), down by two from the previous quarter. Among the largest investors in the company were William Duhamel’s Route One Investment Company (3.61 million shares), Jim Simons’ Renaissance Technologies (3.16 million shares), David Kowitz and Sheldon Kasowitz’s Indus Capital (2.63 million shares), and Vinit Bodas’ Deccan Value Advisors (2.13 million shares).

Follow Herbalife Nutrition Ltd. (NYSE:HLF)
Trade (NYSE:HLF) Now!

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
High River Limited Partnership 4,288,786 0 4,288,786 0 4,288,786 4.61%
Hopper Investments 0 4,288,786 0 4,288,786 4,288,786 4.61%
Barberry Corp 0 4,288,786 0 4,288,786 4,288,786 4.61%
Icahn Partners Master Fund 6,980,001 0 6,980,001 0 6,980,001 7.50%
Icahn Offshore 0 6,980,001 0 6,980,001 6,980,001 7.50%
Icahn Partners 10,175,144 0 10,175,144 0 10,175,144 10.94%
Icahn Onshore 0 10,175,144 0 10,175,144 10,175,144 10.94%
Icahn Capital 0 17,155,145 0 17,155,145 17,155,145 18.44%
IPH GP 0 17,155,145 0 17,155,145 17,155,145 18.44%
Icahn Enterprises Holdings 0 17,155,145 0 17,155,145 17,155,145 18.44%
Icahn Enterprises G.P. Inc 0 17,155,145 0 17,155,145 17,155,145 18.44%
Beckton Corp 0 17,155,145 0 17,155,145 17,155,145 18.44%
Carl C. Icahn 0 21,443,931 0 21,443,931 21,443,931 23.05%
Date of Transaction Amount of Securities Price Per Share High River Limited Partnership

Carl Icahn
Carl Icahn
Icahn Capital LP

Page 1 of 16 – SEC Filing


Washington, D.C. 20549
Under the Securities Exchange Act of 1934
(Amendment No. 9)*
Herbalife Ltd.
(Name of Issuer)
Common Shares, par value $0.001 per Share
(Title of Class of Securities)
(CUSIP Number)
Andrew Langham, Esq.
Icahn Capital LP
767 Fifth Avenue, 47th Floor
New York, New York 10153
(212) 702-4300
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
November 3, 2016
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Section 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  / /.
NOTE:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d‑7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.